NO970284L - Fremgangsmåte ved behandling av opportunistiske infeksjoner med azaspiraner - Google Patents

Fremgangsmåte ved behandling av opportunistiske infeksjoner med azaspiraner

Info

Publication number
NO970284L
NO970284L NO970284A NO970284A NO970284L NO 970284 L NO970284 L NO 970284L NO 970284 A NO970284 A NO 970284A NO 970284 A NO970284 A NO 970284A NO 970284 L NO970284 L NO 970284L
Authority
NO
Norway
Prior art keywords
azaspirans
opportunistic infections
treating opportunistic
treating
infections
Prior art date
Application number
NO970284A
Other languages
English (en)
Other versions
NO970284D0 (no
NO310096B1 (no
Inventor
Alison Mary Badger
Peter John Bugelski
Danuta J Herzyk
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of NO970284D0 publication Critical patent/NO970284D0/no
Publication of NO970284L publication Critical patent/NO970284L/no
Publication of NO310096B1 publication Critical patent/NO310096B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO19970284A 1994-07-23 1997-01-22 Anvendelse av azaspiraner NO310096B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9414902A GB9414902D0 (en) 1994-07-23 1994-07-23 Methods
PCT/US1995/008915 WO1996003126A1 (en) 1994-07-23 1995-07-14 Method of treating opportunistic infections with azaspiranes

Publications (3)

Publication Number Publication Date
NO970284D0 NO970284D0 (no) 1997-01-22
NO970284L true NO970284L (no) 1997-03-19
NO310096B1 NO310096B1 (no) 2001-05-21

Family

ID=10758802

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19970284A NO310096B1 (no) 1994-07-23 1997-01-22 Anvendelse av azaspiraner

Country Status (15)

Country Link
EP (1) EP0804201A4 (no)
JP (1) JPH10503202A (no)
KR (1) KR970704446A (no)
CN (1) CN1157564A (no)
AU (1) AU684384B2 (no)
BR (1) BR9508332A (no)
CA (1) CA2195778A1 (no)
CZ (1) CZ286482B6 (no)
GB (1) GB9414902D0 (no)
HU (1) HUT77379A (no)
MX (1) MX9700626A (no)
NO (1) NO310096B1 (no)
NZ (1) NZ290974A (no)
WO (1) WO1996003126A1 (no)
ZA (1) ZA956098B (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9601909A (pt) * 1995-07-13 1999-10-13 Smithkline Beecham Corp N,n-dietil-8,8-dipropil-2-azaspiro(4,5)decano-2-propan amina dimaleato

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4963557A (en) * 1987-09-28 1990-10-16 Smithkline Beecham Corporation Immunomodulatory azaspiranes
ZA921120B (en) * 1991-02-19 1993-01-27 Smithkline Beecham Corp Cytokine inhibitors
PT100566B (pt) * 1991-06-07 1999-06-30 Smithkline Beecham Corp Azaspiranos imunomoduladores, composicoes farmaceuticas que os contem, sua preparacao e seu uso

Also Published As

Publication number Publication date
JPH10503202A (ja) 1998-03-24
KR970704446A (ko) 1997-09-06
WO1996003126A1 (en) 1996-02-08
HU9700201D0 (en) 1997-04-28
NO970284D0 (no) 1997-01-22
GB9414902D0 (en) 1994-09-14
CN1157564A (zh) 1997-08-20
AU684384B2 (en) 1997-12-11
NO310096B1 (no) 2001-05-21
HUT77379A (hu) 1998-04-28
CZ286482B6 (en) 2000-04-12
AU3190995A (en) 1996-02-22
NZ290974A (en) 1999-08-30
ZA956098B (en) 1996-05-23
MX9700626A (es) 1997-05-31
CZ20997A3 (en) 1997-10-15
EP0804201A4 (en) 2000-04-26
BR9508332A (pt) 1997-11-04
EP0804201A1 (en) 1997-11-05
CA2195778A1 (en) 1996-02-08

Similar Documents

Publication Publication Date Title
NO985591D0 (no) FremgangsmÕte ved uttak av absorberende gjenstander
NO20002172D0 (no) FremgangsmÕte for behandling av hyperkolesterolemi med usubstituert polydiallylamin
NO991955D0 (no) FremgangsmÕte for behandling av hydrokarboner
NO983284D0 (no) Antikoagolante midler egnet i behandling av trombose
NO971468D0 (no) Fremgangsmåte ved behandling av næringsrikt vann
BR9509904A (pt) Processo para purificação e isolamento de 2-desóxi-2,2-difluor-nucleosideos
NO20010117L (no) Fremgangsmåte for behandling av sövnlöshet
NO963322D0 (no) Fremgangsmåte for behandling av abstinens ved stoffmisbruk
BR9400475A (pt) Processo de preparação de zeólita modificada e zeólita modificada
NO308342B1 (no) Dekkark for en absorberende artikkel og fremgangsmÕte ved fremstilling av samme
NO992854D0 (no) FremgangsmÕte ved behandling av celluloseformlegemer
BR9502092A (pt) Conjunto de fechaduras
NO972402D0 (no) Fremgangsmåte for fremstilling av bærere
NO964918D0 (no) Fremgangsmåte ved törking
PT719499E (pt) Processo de tratamento anti-germinativo de tuberculos ou bolbos
DE69717846T2 (de) Behandlungsverfahren von laktamen
NO984145D0 (no) Fremgangsmåte ved behandling av kakao
NO962940D0 (no) Fremgangsmåte ved hydroisomerisering
IS4285A (is) Aðferð við að hindra útfellingu
NO970284D0 (no) Fremgangsmåte ved behandling av opportunistiske infeksjoner med azaspiraner
MD186B1 (ro) Metoda de tratament al endometritei dupa operatia cezariana
NO20006383D0 (no) Fremgangsmåte for behandling
BR9507375A (pt) Tratamento de superficies particuladas
BR9507353A (pt) Método de tratar rinite alérgica
NO962812D0 (no) Fremgangsmåte for behandling av nervebetennelse

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN JANUARY 2003